Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

about

Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

Item

http://www.wikidata.org/entity/Q48106101

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

@en

Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

@nl

type

Item

label

Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

@en

Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

@nl

prefLabel

Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

@en

Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

@nl

P1476

Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

@en

P2093

ISPAD Hypoglycemia Guidelines Writing Group

http://www.w3.org/2001/XMLSchema#string

P2860

Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes

Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012

Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.

Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes

Contemporary rates of severe hypoglycaemia in youth with type 1 diabetes: variability by insulin regimen

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.

Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.

CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.

Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

P304

354-355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PEDI.12600

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Timothy W Jones

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29082592

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

hypoglycemia

P932

7217633

http://www.w3.org/2001/XMLSchema#string